Explore Investments LLC/DE - 25 Jul 2025 SCHEDULE 13G Report for Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL)

Filing Manager: Explore Investments LLC/DE
Reporting Manager: Explore Investments LLC
Security: Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share
Symbol: LYEL
Shares outstanding: 19,277,111 shares
Disclosed Ownership: 1,040,964 shares
Ownership: 5.4%
Form type: SCHEDULE 13G
Filing time: 19 Aug 2025, 16:10:24 UTC
Date of event: 25 Jul 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Explore Investments LLC	5.4%	1,040,964	0	1,040,964	/s/ Paul Dauber	Paul Dauber/its Manager
Jeffrey P. Bezos	5.4%	1,040,964	0	1,040,964	/s/ Jeffrey P. Bezos	Jeffrey P. Bezos/an Individual